Advances in biological therapies for dyslipidemias and atherosclerosis
This article focuses on the latest developments, clinical potential and current challenges of monoclonal antibodies, vaccines and genome/transcriptome modification strategies, including antisense oligonucleotides, genome/base editing and gene therapy.
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Eftaxia-Konstantina Valanti, Katerina Dalakoura-Karagkouni, Gerasimos Siasos, Dimitris Kardassis, Aristides G. Eliopoulos, Despina Sanoudou Source Type: research
More News: Biomedical Science | Cardiology | Cardiovascular | Environmental Health | Gene Therapy | Genetics | Heart | Vaccines